Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NeuroKinetic Medical is a healthcare technology and medical device company focused on preventing and treating early-stage pressure injuries. Its lead product, Prelivia, is an AI-enabled electrical stimulation platform designed for use across hospital, long-term care, and home settings. The company positions the platform as a pressure injury prevention solution with EHR integration, outcomes-based economics, and regulatory clearances including FDA 510(k) and Health Canada clearance, with CE mark timing referenced on its website. NeuroKinetic Medical also highlights clinical evidence including a prospective randomized controlled trial and partnerships with major health systems and medtech companies. The business appears to be centered on commercial deployment of a wound prevention platform rather than a traditional drug-development pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neuro Kinetic.